BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2018
View Archived Issues
Mouse models of high-grade bladder cancer for in vivo evaluation of immunotherapy presented
Read More
Bayer Animal Health discovers anthelmintic compounds
Read More
GS-0976 demonstrates significant hepatic effects in patients with NASH cirrhosis
Read More
Hepagene Therapeutics describes farnesoid X receptor agonists
Read More
MALT1-targeting compounds synthesized by the Dana-Farber Cancer Institute and collaborators
Read More
Prelude Therapeutics identifies PRMT5 inhibitors
Read More
Myalepta receives positive CHMP opinion for generalized and partial lipodystrophy
Read More
Cyxone chooses to complete acquisition of rabeximod
Read More
GERD candidate X-842 safe and well tolerated in first-in-human study
Read More
Dynavax Technologies presents Toll-like receptor 7/8/9 antagonists
Read More
First-in-human results from Millennium's TAK-931 in advanced solid tumors
Read More
PFK/FBPase 1 inhibitors identified at Merck KGaA
Read More
Zenith advances trial of ZEN-3694 in metastatic CRPC into phase II
Read More
Evoke submits NDA to the FDA for Gimoti
Read More
FDA accepts NDA filing for bremelanotide for hypoactive sexual desire disorder
Read More
Interim results presented from phase I trial of PIN-2 in patients with solid tumors
Read More
Versartis and Aravive Biologics enter merger agreement
Read More
FDA approves pegfilgrastim biosimilar Fulphila
Read More
FDA clears Nant to begin clinical trials with neoepitope yeast vaccine YE-NEO-011
Read More
Clovis seeks to expand use of Rubraca in E.U. in recurrent ovarian cancer
Read More
Isomer discovery could yield countless new drugs
Read More
Mabion submits MAA for rituximab biosimilar Mabion-CD20
Read More
Perjeta approved in E.U. for adjuvant treatment of HER2-positive early breast cancer
Read More
Yakult licenses rights to duvelisib in Japan
Read More
Primary efficacy endpoint not achieved in phase II study of teslexivir gel in condyloma
Read More
FDA grants priority review to Hemlibra sBLA
Read More
Preclinical study shows Cynata's MSCs are effective in model of diabetic ulcers
Read More
CytRx launches new subsidiary Centurion Biopharma
Read More
Researchers present first-in-human data for Bayer's BAY-1251152 in advanced cancers
Read More